相关实验视频
Updated: Jan 9, 2026

06:53
Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
12.9K
甲胺对非黑色素瘤皮肤癌的影响:对11个现实世界数据库的分布式网络分析
Yeon-Jung Park1, Man S Kim2, Yoonsung Lee2
1Kyung Hee University College of Medicine, Seoul, Korea.
Annals of dermatology
|December 2, 2025
概括
甲 (HCTZ) 在韩国高血压患者中不会增加非黑色素瘤皮肤癌 (NMSC) 的风险. 这项研究发现HCTZ使用和NMSC发展之间没有关联,无论药物持续时间如何.
科学领域:
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
- 流行病学 流行病学
背景情况:
- 甲 (HCTZ) 是一种具有潜在致癌作用的光敏感药物.
- 之前对HCTZ和皮肤癌风险的研究已经产生了不一致的结果.
- 澄清HCTZ与非黑色素瘤皮肤癌 (NMSC) 之间的关联对于患者安全至关重要.
研究的目的:
- 调查使用酸 (HCTZ) 与患非黑色素瘤皮肤癌 (NMSC) 的风险之间的关联.
- 评估HCTZ对韩国高血压人口中NMSC风险的影响.
- 分析与HCTZ暴露和NMSC相关的剂量反应和亚组影响.
主要方法:
- 这是一项多中心的回顾性队列研究,涉及8,821名患者和来自11家韩国医院的同等数量的对照.
- 数据使用观察医疗结果伙伴关系-通用数据模型进行了标准化.
- 倾向性得分匹配和考克斯回归分析被用来评估HCTZ用户与非用户之间的NMSC风险.
主要成果:
- 甲 (HCTZ) 的使用与非黑色素瘤皮肤癌 (NMSC) 的风险增加没有显著关联 (HR,1.01;95% CI,0.70-1.47).
- 剂量反应分析显示,NMSC风险与HCTZ持续时间 (<1年或≥1年) 之间没有显著的相关性.
- 根据年龄和性别的子组分析没有显示与HCTZ相关的NMSC风险显著增加.
结论:
- 甲 (HCTZ) 与韩国高血压患者的非黑色素瘤皮肤癌 (NMSC) 的发展无关.
- 暴露于HCTZ的持续时间并没有改变观察到的与NMSC风险缺乏关联.
- 这些发现表明,HCTZ可能不会在这个人群中对NMSC构成重大风险.
更多相关视频
11:02The Three-Dimensional Human Skin Reconstruct Model: a Tool to Study Normal Skin and Melanoma Progression
Published on: August 3, 2011
50.7K
04:12Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
Published on: December 19, 2019
15.2K
相关概念视频
Skin Cancer
5.7K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.7K
Cancer Survival Analysis
630
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
630
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K